The communication package to improve drug adherence behavior among vivax malaria patients without G6PD deficiency for malaria elimination along international borders, Northern Thailand

Authors

  • นารถลดา ขันธิกุล Office of Disease Prevention and Control Region 1, Chiang Mai
  • อังคณา แซ่เจ็ง Office of Disease Prevention and Control Region 1, Chiang Mai
  • จินตนา ไชยวัณณ์ Malaria Consortium Asia
  • พัชรินทร์ บุญอินทร์ Bureau of Vector-Borne Diseases,Department of Disease Control
  • สุรเชษฐ์ อรุโณทอง Office of Disease Prevention and Control Region 1, Chiang Mai
  • ประยุทธ สุดาทิพย์ Bureau of Vector-Borne Diseases, Department of Disease Control

DOI:

https://doi.org/10.14456/dcj.2018.33

Keywords:

drug adherence behavior, vivax malaria patients, behavior change communication, chloroquine, primaquine

Abstract

A communication package for malaria Plasmodium vivax patient’s treatment is urgently needed at the first step in malaria elimination program. The objectives of this quasi experimental research were to compare knowledge and perception before and after implementation of a novel tool package, a vivax malaria education program toward the patients and, secondly, to measure levels of patients’ ability of drug adherence, behaviors of taking drugs and satisfaction after receiving this intervention. The research was conducted in public health service units in Mae Hong Son, Chiang Mai and Chiang Rai provinces between January and March 2015. Vivax Malaria patients were screened for G6PD deficiency using Fluorescence spot test (FST), only 36 normal G6PD patients were enrolled after a written informed consent had been obtained for voluntary participation and completion of research procedures. Results showed that the majority of the patients 83.3% (30 out of 36) presented their drug taking behavior with correction, completion and adherence to malaria treatment according to the National Malaria Treatment Guidelines. After the implementation, average scores of knowledge and perception were significantly higher than those before the implementation (p<0.05). Following the implementation, the participants became acutely aware of their ability to comply with drug adherence. Besides that the participants had a high level of satisfaction from malaria clinic services units. The overall feedback from this study is beneficial for public health officers as it could help them be cognizant of socio-cultural factors in developing an innovative intervention program for vivax malaria patients concerning adherence to the drug prescriptions.

References

1. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.

2. สำนักโรคติดต่อนำโดยแมลง กรมควบคุมโรค. ยุทธศาสตร์การกำจัดโรคไข้มาลาเรียประเทศไทย : แผนปฏิบัติการกำจัดโรคไข้มาลาเรียประเทศไทย. กรุงเทพมหานคร: อักษรกราฟฟิก แอนด์ ดีไซน์; 2559.

3. Warrell DA. Clinical features of malaria. In: Warrell DA, Gilles HM, editors. Essential Malariology. 4th ed. Oxford: University of Oxford; 2002.

4. กรมควบคุมโรค กระทรวงสาธารณสุข. แนวทางการวินิจฉัยและดูแลรักษาโรคไข้มาลาเรียประเทศไทย พ.ศ. 2558. กรุงเทพมหานคร: ชุมนุมสหกรณ์การเกษตรแห่งประเทศ; 2558.

5. Ramos Júnior WM, Sardinha JF, Costa MR, Santana MS, Alecrim MG, Lacerda MV. Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon. Braz J Infect Dis 2010;14:410-2.

6. Douglas NM, Pontororing GJ, Lampah DA, Yeo TW, Kenangalem E, Poespoprodjo JR, et al. Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia. BMC Med 2014;12:217.

7. Krudsood S, Tangpukdee N, Muangnoicharoen S, Thanachartwet V, Luplertlop N, Srivilairit S, et al. Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand. Korean J parasitol 2007;45:111-4.

8. Khantikul N, Butraporn P, Kim HS, Leemingsawat S, M.A. Tempongko SB, Suwonkerd W. Adherence to antimalarial drug therapy among vivax malaria patients in Northern Thailand. J Health Popul Nutr 2009;27:4-13.

9. Osterberg L, Blaschke T. Adherence to medication. New Engl J Med 2005;353:487-97.

10. Bloom BS. Learning for mastery. Instruction and curriculum. Regional education laboratory for the Carolinas and Virginia, Topical papers and reprints, number 1 [Internet]. 1968. [cited 2009 Aug 15], Available from: https://files.eric.ed.gov/fulltext/ED053419.pdf

11. วิเชียร เกตุสิงห์. ค่าเฉลี่ยกับการแปลความหมาย : เรื่องง่าย ๆ ที่บางครั้งก็พลาดได้. ข่าวสารการวิจัยการศึกษา 2538;18:8–11.

12. Hlongwana KW, Mabaso MLH, Simon Kunene S, Govender D, Maharaj R. Community knowledge, attitudes and practices (KAP) on malaria in Swaziland: A country earmarked for malaria elimination. Malaria J [Internet]. 2009 [cited 2010 Nov 20];8:29. Available from: https://malariajournal.biomedcentral.com/track/pdf/10.1186/1475-2875-8-29

13. Simpson RJ. Challenges for improving medication adherence. JAMA 2006;296:2614-6.

14. ปาริชาติ สถาปิตานนท์. ระเบียบวิธีวิจัยการสื่อสาร. พิมพ์ครั้งที่ 4. กรุงเทพมหานคร: ด่านสุทธาการพิมพ์; 2549.

15. van Benthem BH, Khantikul N, Panart K, Somboon P, Oskam L. Knowledge and use of prevention measures against malaria in endemic and non-endemic villages in northern Thailand. Southeast Asian J Trop Med Public Health 2006;37:243-9.

16. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. Jama 2002;288:2868-79.

17. Orem DE. Nursing concepts of practice. 3rd ed. New York: McGrew Hill; 1985.

18. Yeboah-Antwi K, Gyapong JO, Asare IK, Barnish G, Evans DB, Adjei S. Impact of prepackaging antimalarial drugs on cost to patients and compliance with treatment. Bull World Health Organ 2001;79:394–9.

19. Cobb S. Social support as a moderator of life stress. Psychosom Med 1976;38:300-14.

20. Sirima SB, Konaté A, Tiono AB, Convelbo N, Cousens S, Pagnomi F. Early treatment of childhood fevers with pre-packed antimalarial drug in the home reduces severe malaria morbidity in Burkina Faso. Trop Med Int Health 2003;8:133-9.

21. Ansah EK, Gyapong JO, Agyepong IA, Evans DB. Improving adherence to malaria treatment for children: the use of pre‐packed chloroquine tablets vs. chloroquine syrup. Trop Med Int Health 2001;6:496-504.

22. Agyepong IA, Ansaha E, Gyapongb M, Adjeic S, Barnishd G, Evanse D. Strategies to improve adherence to recommended chloroquine treatment regimens: a quasi- experiment in the context of integrated primary health care delivery in Ghana. Soc Sci Med 2002;55:2215–26.

23. Kilian AH, Tindyebwa D, Gülck T, Byamukama W, Rubaale T, Kabagambe G, et al. Attitude of women in western Uganda towards pre-packed, unit-dosed malaria treatment for children. Trop Med Int Health 2003;8:431-8.

24. Kolaczinski JH, Ojok N, Opwonya J, Meek S, Collins A. Adherence of community caretakers of children to pre-packaged antimalarial medicines (HOMAPAK®) among internally displaced people in Gulu district, Uganda. Malaria J [Internet]. 2006 [cited 2013 Sep 17];5:40. Available from: https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-5-40

25. Atreja A, Bellam N, Levy SR. Strategies to enhance patient adherence: Making it simple. Med Gen Med [Internet]. 2005 [cited 2009 Aug 15];7:4. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1681370/

Downloads

Published

2018-12-26

How to Cite

1.
ขันธิกุล น, แซ่เจ็ง อ, ไชยวัณณ์ จ, บุญอินทร์ พ, อรุโณทอง ส, สุดาทิพย์ ป. The communication package to improve drug adherence behavior among vivax malaria patients without G6PD deficiency for malaria elimination along international borders, Northern Thailand. Dis Control J [Internet]. 2018 Dec. 26 [cited 2024 Apr. 19];44(4):363-7. Available from: https://he01.tci-thaijo.org/index.php/DCJ/article/view/162729

Issue

Vol. 44 No. 4 (2018): October-December

Section

Original Article

License

Articles published in the Disease Control Journal are considered as academic work, research or analysis of the personal opinion of the authors, not the opinion of the Thailand Department of Disease Control or editorial team. The authors must be responsible for their articles.